China Digital Health Market Analysis Report 2022 to 2030

China Digital Health Market Analysis

$ 3999

China's Digital Health market is projected to grow from $16.96 Bn in 2022 to $73.42 Bn by 2030, registering a CAGR of 20.1% during the forecast period of 2022-30. Driven by national initiatives, population expansion, and diversified healthcare requirements, China's healthcare industry is experiencing faster innovation and adoption. The market is segmented by solution, by deployment, and by end-use. Some of the major players include Alibaba Group Holding Limited, Ping An Good Doctor & Cerner Corporation.

ID: IN10CNDH005 CATEGORY: Digital Health GEOGRAPHY: China

Buy Now

China Digital Health Market Executive Summary

China's Digital Health market is projected to grow from $16.96 Bn in 2022 to $73.42 Bn by 2030, registering a CAGR of 20.1% during the forecast period of 2022-30. China's healthcare industry has been growing rapidly in recent years, driven by factors such as an aging population and increased government spending. According to World Health Organization (WHO) Global Health Expenditure database, health expenditure (% of GDP) in China has grown from 5.17% in 2018 to 5.35% in 2019 and is predicted to decrease dramatically from 8.1 percent in 2021 to 2.8 percent in 2022 due to widespread outbreak of Omicron.

The Chinese government has been supporting digital healthcare development in order to expand access to healthcare services, particularly in rural regions. This includes programs like telemedicine, which allows patients to obtain medical consultations from a distance, and the use of Electronic Medical Records (EMRs), Video consultations with physicians, remote monitoring of patient's health status, and the use of mobile applications to track symptoms and manage chronic diseases are used to enhance healthcare delivery efficiency. They have been widely impactful in providing convenience and accessibility to patients and potentially lowering healthcare costs in China. Moreover, numerous private businesses in China are engaging in digital healthcare. Tencent, the firm behind the popular messaging app WeChat, has created a healthcare platform that allows users to get medical consultations, acquire prescription medications, and schedule doctor visits.

China Digital Health Market

Market Dynamics

Market Growth Drivers

Owing to government assistance, expanding smartphone penetration, an older population, rising healthcare expenditures, and private sector investments, China's digital healthcare sector is growing rapidly post COVID – 19 pandemic. Moreover, the growing usage of cell phones has simplified access to digital healthcare services. The aging population is also placing pressure on the healthcare system, which digital healthcare can assist to alleviate. Many private firms, like Tencent, Alibaba, JD.com, and Ping An, have invested in digital healthcare and provide a range of digital health services.

Market Restraints

Laws and regulations in the healthcare industry do not always keep up with innovative applications of new technology. Data privacy and security are core issues in the digital health market of China. The current liability structure may be unable to offer appropriate and effective solutions for infringements regarding emerging digital healthcare services and products.

Competitive Landscape

Key Players

Alibaba Group Holding Limited (CHN)
WeDoctor (CHN)
DXY(CHN)
Ping An Good Doctor (CHN)
Cerner Corporation (USA)
Mckesson Corporation (USA)

Notable Recent Deals

April 2021: Cerner Corporation acquired Kantar Health, a division of Kantar Group, for $375 million in cash, subject to adjustment.

October 2019: Cerner Corporation acquired AbleVets—a strategic IT consulting and engineering firm—as a wholly-owned subsidiary.

Healthcare Policies and Regulatory Landscape

National Healthcare Security Administration (NHSA) is primarily in charge of the state-sponsored China Healthcare Security program, which includes a general health insurance plan, maternity insurance, and medical aid programs. It regulates the administration of the insurance fund, and centralized pharmaceutical and medical supply procurement.

As outlined in the "Healthy China 2030" strategy, the government has issued the "China Health Act (2019-2030)," "Opinions on Deepening the Reform of the Medical Security System," and other guiding programs to expedite the establishment of a multi-dimensional medical security system and an integrated healthcare service system.

In April 2022, the Ministry of Science and Technology issued the Implementing Rules of Administrative Regulations on Human Genetic Resources Management. Moreover, The National Health Commission (NHC) declared in February 2022 that it will work to optimize the pricing management of "Internet plus Healthcare" services and plans through payment by the medical insurance fund.

Reimbursement Scenario

Public and private medical facilities, as well as insurance programs, make up China's healthcare system. According to statistics released by the National Healthcare Security Administration (NHSA), formerly known as the Ministry of Human Resources and Social Security (MOHRSS), more than 1.3 Bn people, or over 95% of the population, were covered by public medical insurance at the end of 2011. Additionally, 1.36 Bn people will have access to public health insurance as of June 2022, according to the most recent government statistics.

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Digital Health Market Segmentation

The Digital Health Market is segmented as mentioned below:

By Solution (Revenue, USD Billion):

Software
Services

By Deployment (Revenue, USD Billion):

Cloud-based
On-premises

By End-use (Revenue, USD Billion):

Diagnostic Centres
Healthcare Payers
Healthcare Research Centres
Hospitals & Clinics
Nursing Care Centres
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.